Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-21
1989-11-14
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548154, 548151, 548126, 544184, 544281, 544330, 544350, 568337, 514243, 514249, 514258, 514363, 514366, A61K 31425, C07D51304, C07D48704
Patent
active
048808245
ABSTRACT:
Heterocyclic compounds of formulae (I) and (II): ##STR1## where R.sup.1 and R.sup.2 are alkyl, R.sup.3 is H or alkyl, m is 2-5 and Het is a hetercycle such as thiazole, benzothiazole, substituted benzothiazole, pyrazine, triazine, thiadiazole, substituted thiadiazole, pyrimidine or substituted pyrimidine. The compounds are calcium channel blockers useful in the treatment of cardiovascular conditions such as hypertension or angina.
REFERENCES:
patent: 4103012 (1978-07-01), Gubin et al.
patent: 4386092 (1983-05-01), Oe et al.
patent: 4727145 (1988-02-01), Press et al.
Abstract for WO84/167332 (1984).
Yoshitomi Pharmaceutical, Chemical Abstract, vol. 101, No. 151851h (1984).
Burger, Medicinal Chemistry, pp. 72-75 (1960).
Press Jeffery B.
Urbanski Maud
Bernhardt E.
Ortho Pharmaceutical Corporation
Shah Mukund J.
LandOfFree
Phenyl and benzoyl substituted imidazo-fused heterocyclic calciu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl and benzoyl substituted imidazo-fused heterocyclic calciu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl and benzoyl substituted imidazo-fused heterocyclic calciu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853208